Contact
Olivia Tatti
Email
+32 (0)472 33 84 01
iTeos Therapeutics is a publicly-held (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing next generation immunotherapies.
Based in Gosselies, Belgium and Cambridge, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute (UCLouvain) in 2011.
In March 2020, the Company completed a $125 million Series B2 financing, and in July 2020, we completed our IPO raising over $230million of gross proceeds. In June 2021, iTeos entered into a transformative $2.145 billion co-development and co-commercialization agreement with GSK for EOS-448, iTeos’s anti-TIGITmonoclonal antibody. As a well-capitalized biotech company iTeos is positioned to continue to develop our clinical pipeline and maintain our investments in our discovery research team to leverage our fantastic science to improve the lives of cancer patients.
For more information, please visit www.iteostherapeutics.com.
iTeos Therapeutics is now a world-class biotech in cancer immunotherapy. To carry on its growth, expand its pipeline and reinforce its team, iTeos Therapeutics is looking for a Research Assistant - TM
Within its Translational Medicine (TM) Department, iTeos is currently actively looking for a highly motivated Research Assistant with expertise in immunological assays and ideally experience in deep analyses (such as multi-parameter flow cytometry, RNA sequencing or spatial analyses) of pre-clinical and clinical samples to take a key role in the growing reverse translation group. The selected candidate will work in close interaction with Translational Medicine Leads and scientists from TM and discovery to produce laboratory data with the aim of developing a deeper understanding of mechanisms of action, providing rationale for combinations and for patient selection of both clinical stage assets and emerging programs. He/she will also be responsible for data analysis and interpretation including running relevant statistical tests.validation of innovative targets with the goal to develop breakthrough cancer immunotherapies.
Main responsibilities:
Your application and related information will remain strictly confidential.